Valuation: Karex

Market Cap 41Cr 10Cr 9.11Cr 8.43Cr 7.6Cr 14Cr 947.91Cr 15Cr 101.23Cr 40Cr 506.35Cr 38Cr 37Cr 1.61TCr P/E 2027 *
21.7x
P/E 2028 * 12.4x
Enterprise Value 35Cr 8.48Cr 7.69Cr 7.11Cr 6.42Cr 12Cr 800.02Cr 13Cr 85Cr 34Cr 427.35Cr 32Cr 31Cr 1.36TCr EV / Sales 2027 *
0.67x
EV / Sales 2028 * 0.62x
Free-Float
39.68%
Yield 2027 *
2.39%
Yield 2028 * 3.59%
1 week-4.88%
Current month-6.02%
1 month-15.22%
3 months-20.41%
6 months-25.00%
Current year-44.68%
1 week 0.38
Extreme 0.38
0.41
1 month 0.38
Extreme 0.38
0.48
Current year 0.38
Extreme 0.38
0.73
1 year 0.38
Extreme 0.38
0.8
3 years 0.38
Extreme 0.38
1.09
5 years 0.32
Extreme 0.325
1.09
10 years 0.26
Extreme 0.26
2.62
Manager TitleAgeSince
Chief Executive Officer 48 29/07/2013
Director of Finance/CFO 49 30/06/2025
Chief Tech/Sci/R&D Officer 71 27/09/2012
Director TitleAgeSince
Director/Board Member 71 27/09/2012
Director/Board Member 83 30/11/2012
Director/Board Member 48 25/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
16/07/26 Free

Director

80,000 0.0076%
16/07/26 Free

Chief Technology Officer

80,000 0.0076%
16/07/26 Free

Chief Executive Officer

80,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.88%-50.94%-35.00% 10Cr
+1.05%+2.66%+14.76%+11.37% 39TCr
+0.97%+0.31%+25.65%+8.81% 27TCr
+1.20%+1.17%-2.86%+12.29% 14TCr
+1.81%+3.22%+26.50%+31.23% 7.92TCr
+2.09%+0.92%+4.77%-9.73% 6.72TCr
-1.54%-0.18%+27.35% - 5.32TCr
+0.96%-0.28%-17.22%-19.58% 4.97TCr
+1.12%+1.54%+24.28%-1.74% 4.05TCr
+0.93%+5.42%+22.36%+42.16% 2.27TCr
Average +0.86%+0.99%+7.46%+4.42% 11TCr
Weighted average by Cap. +1.04%+1.59%+15.01%+9.71%

Financials

2027 *2028 *
Net sales 52Cr 13Cr 11Cr 11Cr 9.53Cr 18Cr 1.19TCr 19Cr 126.93Cr 50Cr 634.92Cr 47Cr 46Cr 2.02TCr 56Cr 14Cr 13Cr 12Cr 10Cr 20Cr 1.3TCr 20Cr 139.02Cr 55Cr 695.39Cr 52Cr 51Cr 2.21TCr
Net income 1.92Cr 46.98L 42.57L 39.38L 35.53L 66.96L 44Cr 69.32L 4.73Cr 1.88Cr 24Cr 1.76Cr 1.73Cr 75Cr 3.33Cr 81.48L 73.84L 68.3L 61.62L 1.16Cr 77Cr 1.2Cr 8.2Cr 3.25Cr 41Cr 3.06Cr 2.99Cr 130.28Cr
Net Debt -6.41Cr -1.57Cr -1.42Cr -1.31Cr -1.19Cr -2.24Cr -147.89Cr -2.31Cr -16Cr -6.26Cr -79Cr -5.89Cr -5.76Cr -250.77Cr -6.32Cr -1.55Cr -1.4Cr -1.3Cr -1.17Cr -2.2Cr -145.82Cr -2.28Cr -16Cr -6.17Cr -78Cr -5.8Cr -5.68Cr -247.25Cr
Projected Income Statement - Annual - Karex
Logo Karex
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd. are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants, and others. Its subsidiary, Karex Marketing Sdn. Bhd. engages in manufacturing and selling hand sanitizers, condoms, personal lubricants, and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd. are engaged in investment holding activity.
Employees
2,965
Date Price Change Volume
13/26/13 MYR 0.3900 0.00% 5,89,100
12/26/12 MYR 0.3900 0.00% 13,07,500
11/26/11 MYR 0.3900 -3.70% 3,07,500
10/26/10 MYR 0.4050 -1.22% 6,57,200
06/26/06 MYR 0.4100 -3.53% 7,55,500
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Karex
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3900MYR
Average target price
0.5833MYR
Spread / Average Target
+49.57%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Karex
  1. Stock Market
  2. Stocks
  3. 5247 Stock